TY -的盟Kazi Abdul Momin盟卡齐,萨阿德·艾哈迈德盟——Ahsan Nazia非盟主席,Sadori盟——Sameen Fareeha AU - Saqib,默罕默德盟——汗莫卧儿王朝,穆罕默德•阿尤布AU - Wajidali Zabin AU -阿里,兹亚盟-艾哈迈德,饶撅嘴盟——Kalimuddin Hussain盟——劳夫,亚希尔AU -马哈茂德,法蒂玛盟——征服者,Saad盟——Abbasi Tufail Ahmad盟——Khoumbati Khalil-Ur-Rahmen盟——Abbasi AU - Stergioulas穆尼尔消息K PY - 2020 DA - 2020/9/3 TI -数字卫生干预措施在巴基斯坦目前的挑战:混合方法分析乔- J地中海互联网Res SP - e21691六世22 - 9千瓦-数字医疗KW -电子健康KW - LMICs KW - mHealth KW -巴基斯坦KW - SWOT KW -远程医疗AB -背景:数字健康具备在低收入和中等收入国家(LMICs)彻底改变卫生保健,在某种程度上,增加手机访问和网络连接。本文评估了可能促进或阻碍巴基斯坦数字卫生进展的潜在因素。目标:本研究的目标是确定巴基斯坦目前正在开展的数字卫生项目和研究，以及参与这些举措的主要利益攸关方。我们的目标是遵循混合方法战略，并通过优势、劣势、机会和威胁(SWOT)分析来评估这些项目和研究，以确定可能促进或阻碍巴基斯坦数字卫生进展的内部和外部因素。方法:本研究旨在评估巴基斯坦过去5年采用混合方法开展的数字卫生项目。根据世界卫生组织(WHO)推荐的卫生系统研究构建模块对从实地调查中获得的定性和定量数据进行分类，并使用SWOT分析策略对数据进行分析。结果:在巴基斯坦过去5年中开展的数字卫生项目中，研究了51个。在这些项目中，46%(23/51)使用技术进行研究，30%(15/51)使用技术进行执行，12%(6/51)使用技术进行应用程序开发。目标健康领域为一般健康(23/51,46%)、免疫(13/51,26%)和诊断(5/51,10%)。 Smartphones and devices were used in 55% (28/51) of the interventions, and 59% (30/51) of projects included plans for scaling up. Artificial intelligence (AI) or machine learning (ML) was used in 31% (16/51) of projects, and 74% (38/51) of interventions were being evaluated. The barriers faced by developers during the implementation phase included the populations’ inability to use the technology or mobile phones in 21% (11/51) of projects, costs in 16% (8/51) of projects, and privacy concerns in 12% (6/51) of projects. Conclusions: We conclude that while digital health has a promising future in Pakistan, it is still in its infancy at the time of this study. However, due to the coronavirus disease 2019 (COVID-19) pandemic, there is an increase in demand for digital health and implementation of health outcomes following global social distancing protocols, especially in LMICs. Hence, there is a need for active involvement by public and private organizations to regulate, mobilize, and expand the digital health sector for the improvement of health care systems in countries. SN - 1438-8871 UR - //www.mybigtv.com/2020/9/e21691 UR - https://doi.org/10.2196/21691 UR - http://www.ncbi.nlm.nih.gov/pubmed/32880584 DO - 10.2196/21691 ID - info:doi/10.2196/21691 ER -